Comparison of the Efficacy of Topical Clindamycin versus Niacinamide in the Treatment of Mild to Moderate Acne Vulgaris: a Systematic Review
Background: Acne vulgaris (AV) is one of the most common skin diseases among teenagers and is treated based on its severity. Mild acne is treated with topical agents, while moderate and severe acne are treated with a combination of topical and systemic agents. Topical agents that are often used for acne are antibiotics, such as topical clindamycin. Widespread use of antibiotics to treat AV causes resistance problems. Therefore, alternative therapies are needed to prevent resistance to topical clindamycin, such as topical niacinamide, which has anti-inflammatory effects without inducing resistance problems. Purpose: To compare the efficacy of topical clindamycin and topical niacinamide in mild to moderate AV. Methods: In this systematic review, a literature search was carried out through 6 databases, following PRISMA 2020 guidelines. Inclusion criteria were written in English or Indonesian, published in 2010-2020, randomized controlled trial (RCT) study design, conducted on human samples, and discussed the efficacy comparison of topical clindamycin and niacinamide in mild to moderate AV. Studies that were not accessible in full-text and based on secondary data were excluded. Quality and risk of bias assessments were done using The Jadad Scale and Risk of Bias 2 (RoB 2). Result: Acne severity was reduced significantly in both topical clindamycin and niacinamide groups, and there was no efficacy difference between these groups. Both topical clindamycin and topical niacinamide can cause mild side effects. Conclusion: Topical niacinamide can be an alternative therapy to topical clindamycin because they are both effective in treating mild to moderate AV.
Mohiuddin A. A comprehensive review of acne vulgaris. J Clin Pharm. 2019;1(1):17–45.
Movita T. Acne vulgaris. Contin Med Educ. 2013;40(4):269–72.
Zaenglein A, Graber E, Thiboutot D. Acne vulgaris and acneiform eruptions. In: Goldsmith L, Katz S, Gilchrest B, Paller A, Leffell D, Wolff K, editors. Fitzpatrick’s Dermatology in General Medicine. 8th ed. New York: McGraw-Hill; 2012. p. 897–917.
Agustin M. Hubungan antara derajat keparahan akne vulgaris dengan tingkat kualitas hidup pada siswa kelas VIII dan IX Madrasah Tsanawiyah Pembangunan UIN Jakarta Tahun ajaran 2016-2017 [Internet]. UIN Syarif Hidayatullah Jakarta; 2016. Available from: http://repository.uinjkt.ac.id/dspace/handle/123456789/37391.
Anggraeni S, Setyaningrum T, Listiawan Y. Perbedaan Kadar Malondialdehid (MDA) sebagai Petanda Stres Oksidatif pada Berbagai Derajat Akne Vulgaris.Berkala Ilmu Kesehatan Kulit dan Kelamin. 2017;29(1):36–43.
Tanghetti EA, Kawata AK, Daniels SR, Yeomans K, Burk CT, Callender VD. Understanding the burden of adult female acne. J Clin Aesthet Dermatol. 2014;7(2):22–30.
Sibero, HT, Putra, IWA, Anggraini D. Tatalaksana terkini acne vulgaris. J Kedokt Unila. 2019;3(2):313–20.
Perhimpunan Dokter Spesialis Kulit dan Kelamin Indonesia (PERDOSKI). Panduan Praktik Klinik Bagi Dokter Spesialis Kulit Dan Kelamin Di Indonesia. Jakarta: PERDOSKI; 2017.
Walocko FM, Eber AE, Keri JE, AL-Harbi MA, Nouri K. The role of nicotinamide in acne treatment. Dermatol Ther. 2017;30(5):1–7.
Luk NMT, Hui M, Lee HCS, Fu LH, Liu ZH, Lam LY, et al. Antibiotic-resistant Propionibacterium acnes among acne patients in a regional skin centre in Hong Kong. J Eur Acad Dermatology Venereol. 2011;27(1):31–6.
Scholz CF, Kilian M. The natural history of cutaneous propionibacteria, and reclassification of selected species within the genus Propionibacterium to the proposed novel genera Acidipropionibacterium gen. nov., Cutibacteriumgen. nov. and Pseudopropionibacterium gen. nov. Int J Syst Evol Microbiol. 2016;66(11):4422–32.
Nguyen TA, Eichenfield LF. Profile of clindamycin phosphate 1.2%/benzoyl peroxide 3.75% aqueous gel for the treatment of acne vulgaris. Clin Cosmet Investig Dermatol. 2015;8:549.
Shahmoradi, Z, Iraji, F, Siadat, AH, & Ghorbaini A. Comparison of topical 5% nicotinamid gel versus 2% clindamycin gel in the treatment of the mild-moderate acne vulgaris: A double-blinded randomized clinical trial. J Res Med Sci Off J Isfahan Univ Med Sci. 2013;18(2):115–7.
Nugroho R, Widayati R. Terapi topikal clindamycin dibandingkan dengan niacinamide + zinc pada acne vulgaris. J Kedokt Diponegoro.
Khodaeiani E, Fouladi RF, Amirnia M, Saeidi M, Karimi ER. Topical 4% nicotinamide vs. 1% clindamycin in moderate inflammatory acne vulgaris. Int J Dermatol. 2013;52(8):999–1004.
Cervantes J, Eber AE, Perper M, Nascimento VM, Nouri K, Keri JE. The role of zinc in the treatment of acne : A review of the literature. Dermatol Ther. 2017;31(1):1–17.
Cunliffe W, Fernandez C, Bojar R, Kanis R, West F. An observer-blind, parallel-group, randomized, multicentre clinical and microbiological study of a topical clindamycin/zinc gel and a topical clindamycin lotion in patients with mild/moderate acne. 2005;16(4):213–8.
- Copyright of the article is transferred to the journal, by the knowledge of the author, whilst the moral right of the publication belongs to the author.
- The legal formal aspect of journal publication accessibility refers to Creative Commons Atribusi-Non Commercial-Share alike (CC BY-NC-SA), (https://creativecommons.org/licenses/by-nc-sa/4.0/)
- The articles published in the journal are open access and can be used for non-commercial purposes. Other than the aims mentioned above, the editorial board is not responsible for copyright violation
The manuscript authentic and copyright statement submission can be downloaded ON THIS FORM.